These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20216989)

  • 1. Association between the Thr325Ile polymorphism of the thrombin-activatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study.
    Kozian DH; Lorenz M; März W; Cousin E; Mace S; Deleuze JF
    Thromb Haemost; 2010 May; 103(5):976-83. PubMed ID: 20216989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.
    Tàssies D; Roqué M; Monteagudo J; Martorell T; Sionis A; Arzamendi D; Heras M; Reverter JC
    Thromb Res; 2009 Nov; 124(5):614-8. PubMed ID: 19699511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
    Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
    Ladenvall C; Gils A; Jood K; Blomstrand C; Declerck PJ; Jern C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):955-62. PubMed ID: 17272741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
    Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM; Cooper AJ; Lwaleed BA
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.
    Ricart JM; Ramón LA; Vayá A; España F; Santaolaria ML; Todolí J; Castelló R; Fontcuberta J; Estellés A
    Br J Haematol; 2008 May; 141(5):716-9. PubMed ID: 18341631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosis.
    Martinez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J
    Am J Reprod Immunol; 2009 Dec; 62(6):381-9. PubMed ID: 19895374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
    Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
    Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
    Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.
    Akatsu H; Yamagata H; Chen Y; Miki T; Kamino K; Takeda M; Campbell W; Kondo I; Kosaka K; Yamamoto T; Okada H
    Br J Haematol; 2004 Nov; 127(4):440-7. PubMed ID: 15521922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the Thr325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease.
    Verdú J; Marco P; Benlloch S; Lucas J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):494-5. PubMed ID: 18160566
    [No Abstract]   [Full Text] [Related]  

  • 16. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
    Martínez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J
    J Reprod Immunol; 2010 Nov; 86(2):133-40. PubMed ID: 20594598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.
    Brouwers GJ; Leebeek FW; Tanck MW; Wouter Jukema J; Kluft C; de Maat MP
    Thromb Haemost; 2003 Jul; 90(1):92-100. PubMed ID: 12876631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN; Mosnier LO
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
    Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
    Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
    Boffa MB; Koschinsky ML
    Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.